Search

Library Entry

2019 Meet-the-Expert Webinar Series: Careers in Industry (Presentation Slides)

This one-hour webinar, moderated by Sruthi Ravindranathan, PhD (Emory University), and presented by Vionni W.C. Yu, PhD (Novartis Institutes for Biomedical Research), taught early career scientists about strategies and tactics for a successful career in industry. The webinar featured an...

2019 MTE Webinar - Careers in Industry.pdf

Library Entry

2019 Meet-the-Expert Webinar Series: Careers in Industry (Recording)

This one-hour webinar, moderated by Sruthi Ravindranathan, PhD (Emory University), and presented by Vionni W.C. Yu, PhD (Novartis Institutes for Biomedical Research), taught early career scientists about strategies and tactics for a successful career in industry. The webinar featured an...

Library Entry

Triage and Management of Pyrexia

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses triage and management of pyrexia in patients receiving BRAF/MEK inhibitor therapy. Click here to watch "Triage and Management of Pyrexia" #Melanoma #Video #CollaborativePartner #AdverseEvents ...

Library Entry

Management of Cardiac AEs Associated With BRAF/MEK Inhibitor Therapy

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses the management of cardiac AEs associated with BRAF/MEK inhibitor therapy. Click here to watch "Management of Cardiac AEs Associated with BRAF/MEK Inhibitor Therapy" #Melanoma #Video #CollaborativePartner...

Library Entry

Steps to Recognize and Manage Ocular AEs Associated with BRAF/MEK Inhibitor Therapy

In this video, Lisa A. Kottschade, APRN, MSN, CNP, of the Mayo Clinic, discusses the steps to recognize and manage ocular AEs associated with BRAF/MEK inhibitor therapy. Click here to watch "Steps to Recognize and Manage Ocular AEs Associated with BRAF/MEK Inhibitor Therapy" #Melanoma ...

Library Entry

A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article that describes the discovery of a naturally occurring T-cell clone which expressed high-affinity HLA-A*02:01 (A*02)-restricted TCR against NY-ESO-1 from a patient who had NY-ESO-1-expressing ovarian tumor. ...

Library Entry

Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-se

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report on patients treated with immune-checkpoint blockade followed by targeted therapy, or vice versa, who experienced cutaneous toxicities with unique histological patterns, a feature that has not been well described in...

Library Entry

Advances in Cancer Immunotherapy™ Webinar Series - Updates from the Field: ESMO Congress Clinical Trials Recording

This webinar provided an update on developments in the field relating to content presented at the Advances in Cancer Immunotherapy programs and focused on applicable information for a clinical audience. More specifically, program organizers Theodore F. Logan, MD, and David F. McDermott, MD,...

Library Entry

Primer on Cancer Immunology and Immunotherapy

Primer on Cancer Immunology and Immunotherapy International Conference on Immunotherapy Radiotherapy Combinations September 20, 2018 Presentered by Gustave Roussy and SOCRATE, in collaboration with the Society for Immunotherapy of Cancer Program Summary Over 420 attendees from 4 continents,...

7 attachments

Library Entry

Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article where researchers investigated the roles of humoral and cellular autoimmunity in the development of thyroid cancer and the likelihood of less aggressive behavior in the setting of Graves disease, combining...